- Home
- LPCN vs MDIA Comparison
LPCN vs MDIA Comparison
Compare LPCN & MDIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPCN | MDIA |
|---|---|---|
| Founded | 1997 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 50.0M |
| IPO Year | 2011 | 2019 |
Fundamental Metrics
Financial Performance| Metric | LPCN | MDIA |
|---|---|---|
| Price | $7.58 | $0.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 96.6K | 15.9K |
| Earning Date | 03-10-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 46.18 | ★ 80.00 |
| EPS | N/A | ★ N/A |
| Revenue | $1,976,677.00 | ★ $95,571,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $74.43 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 195.05 |
| 52 Week Low | $2.52 | $0.54 |
| 52 Week High | $12.37 | $1.60 |
Technical Indicators
Market Signals| Indicator | LPCN | MDIA |
|---|---|---|
| Relative Strength Index (RSI) | 46.08 | 51.50 |
| Support Level | $2.87 | $0.56 |
| Resistance Level | $8.35 | $0.65 |
| Average True Range (ATR) | 0.68 | 0.04 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 29.30 | 48.02 |
Price Performance
Historical ComparisonAbout LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.